Literature DB >> 27338034

Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults.

Seung-Kwon Myung1,2,3,4, Chan Wha Lee2,5, Jeonghee Lee4, Jeongseon Kim1,4, Hyeon Suk Kim6.   

Abstract

PURPOSE: Although the incidence of thyroid cancer in Korea has rapidly increased over the past decade, few studies have investigated its risk factors. This study examined the risk factors for thyroid cancer in Korean adults.
MATERIALS AND METHODS: The study design was a hospital-based case-control study. Between August 2002 and December 2011, a total of 802 thyroid cancer cases out of 34,211 patients screened from the Cancer Screenee. Cohort of the National Cancer Center in South Korea were included in the analysis. A total of 802 control cases were selected from the same cohort, and matched individually (1:1) by age (±2 years) and area of residence for control group 1 and additionally by sex for control group 2.
RESULTS: Multivariate conditional logistic regression analysis using the control group 1 showed that females and those with a family history of thyroid cancer had an increased risk of thyroid cancer, whereas ever-smokers and those with a higher monthly household income had a decreased risk of thyroid cancer. On the other hand, the analysis using control group 2 showed that a family history of cancer and alcohol consumption were associated with a decreased risk of thyroid cancer, whereas higher body mass index (BMI) and family history of thyroid cancer were associated with an increased risk of thyroid cancer.
CONCLUSION: These findings suggest that females, those with a family history of thyroid cancer, those with a higher BMI, non-smokers, non-drinkers, and those with a lower monthly household income have an increased risk of developing thyroid cancer.

Entities:  

Keywords:  Alcohols; Case-control studies; Risk factors; Smoking; Thyroid neoplasms

Mesh:

Year:  2016        PMID: 27338034      PMCID: PMC5266399          DOI: 10.4143/crt.2015.310

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


Introduction

According to the World Cancer Report 2014, thyroid cancer is one of the less frequent cancers worldwide [1]. Its incidence, however, has increased almost two-fold over the past few decades, due mainly to the increased detection of thyroid cancer using thyroid ultrasonography [1,2]. In particular, the incidence rate of thyroid cancer in South Korea in 2011 was 15 times higher than in 1993 [3]. Although the precise causes of thyroid cancer remain unclear, a few risk factors, such as exposure to radiation, sex (women), and a diet low in iodine (follicular thyroid cancer) are known to increase the risk of thyroid cancer [4]. Recently, several lifestyle factors have been suggested to have an association with the risk of developing thyroid cancer from the findings of observational studies. According to Schmid et al.’s meta-analysis [5] of case-control and cohort studies in 2013, there was no overall significant association between physical activity and thyroid cancers, even though subgroup analyses revealed inconsistent findings according to the study design. In 2012, Zhao et al. [6] reported that overweight and obesity increased the risk of thyroid cancer significantly (by 18%) from the findings of a meta-analysis of seven cohort studies. On the contrary, unlike other cancers, a pooled analysis of five prospective studies in the United States suggested that cigarette smoking and alcohol consumption were associated with a decreased risk of thyroid cancer [7]. In addition, Cho and Kim [8] reported that the risk of thyroid cancer was decreased by 21% in ever-smokers compared to never-smokers when they performed a meta-analysis of 31 observational studies [8]. As described before, the age-standardized incidence of thyroid cancer in Korea women (88.6 per 100,000) has increased rapidly and is the highest among all countries in the world (20 per 100,000 for the United States, 12.7 for Australia, and 6.1 per 100,000 for world) [9]. Despite this, few studies have reported the risk factors for thyroid cancer in Korean adults. Moreover, the sample sizes of previous case-control studies on this issue were small. This study examined the risk factors for thyroid cancer in Korean adults using a hospital-based case-control study.

Materials and Methods

1. Study population

A large hospital-based case-control study was conducted using the data from the Cancer Screenee Cohort of the National Cancer Center in South Korea. All participants were men and women aged between 30 and 70 years, who underwent health screening examinations including thyroid ultrasonography. All the participants were asked to complete a self-administered questionnaire about their sociodemographic characteristics (e.g., age, education, occupation, household income, and marital status), cigarette smoking habits, alcohol drinking habits, and their regular exercise habits. A total of 34,211 participants provided written informed consent for study participation between August 2002 and December 2011.

2. Case and control selection

The thyroid cancer cases were defined based on the International Classification of Diseases for Oncology (ICD-O) (code C73) and were ascertained by a linkage to the Korea Central Cancer Registry (KCCR) database, which has been used to identify the incidence of cancer in Korea. Among the 828 thyroid cancer patients, a total of 802 patients were finally selected after excluding those who did not answer the questionnaire. The controls were selected from the same cohort with 34,211 participants, who underwent health screening examinations including thyroid ultrasonography. Among the potential controls (n=31,453) who were not diagnosed with any cancer including thyroid cancer, 2,962 participants were excluded due to missing questionnaires or insufficient information on their residential areas. From the remaining 28,491 participants, using an incidence density sampling method, one control was selected randomly for each thyroid cancer case from the appropriate risk sets consisting of all study participants, free of cancer. Those in control group 1 were matched individually to the cases according to age (within 2 years) and residential area (Seoul, Gyeonggi, Gangwon, Chungcheong, Jeolla, Gyeongsang, Jeju, North America, and other Asian countries). In control group 1, sex was not included as a matching variable to determine if sex is associated with the risk of thyroid cancer. In addition, the controls for control group 2 were matched to cases by age (within 2 years), residential areas Seoul, Gyeonggi, Gangwon, Chungcheong, Jeolla, Gyeongsang, Jeju, North America, and other Asian countries), and also sex to reduce the confounding effect of sex. A total of 802 incident cases and 802 controls were included for the final analysis. The study procedure including the linkage to the KCCR database was approved by the institutional review board of the National Cancer Center (NCC2014-0096).

3. Statistical methods

To assess the association between the risk factors and thyroid cancer, conditional logistic regression models were used to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) using univariate and multivariate analyses. The multivariate conditional logistic regression models were adjusted for sex (female vs. male), body mass index (BMI, kg/m2: < 23, 23-25, ≥ 25), family history of cancer (first degree relative: yes vs. no), family history of thyroid cancer (first degree relative: yes vs. no), education (college or above, high school vs. middle school or below), occupation (agriculture/laborer/unemployed/others, sales/service, profession/office worker vs. housewife), monthly household income (> $3,706 or $1,853-$3,706 vs. < $1,853), marital status (divorced/widowed, unmarried vs. married), alcohol consumption (ever-drinker, current drinker, former drinker vs. non-drinker), and smoking status (ever-smoker, current smoker, former smoker vs. non-smoker). In addition, the Cochran-Armitage test for trend was conducted to investigate the relationship between increasing exposure to smoking and thyroid cancer risk. All the analyses were performed for both control groups 1 and 2. The goodness of fit of a model was measured by the generalized R2 statistic that Allison discussed [10] as follows: , where likelihood ratio test statistic (LRT)=–2logL(0)– [–2logL(p)], n is the sample size, logL(0) is the log-likelihood for a null model with no covariates, and logL(p) is the log-likelihood for the fitted model with p covariates. All statistical analyses were performed using SAS ver. 9.3 software (SAS Institute Inc., Cary, NC).

Results

Table 1 lists the distribution of the general characteristics among the 1,604 participants with thyroid cancer (n=802) and control cases (n=802) in the control group 1 according to sex, BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status. In univariate analysis, females (OR, 2.97; 95% CI, 2.38 to 3.71), family history of thyroid cancer (OR, 3.64; 95% CI, 1.87 to 7.09), and divorced or widowed (OR, 2.38; 95% CI, 1.54 to 3.67) were associated with an increased risk of thyroid cancer, whereas a family history of cancer, higher education levels, other occupations (other than housewife), higher monthly household incomes, alcohol consumption, and ever-smokers were associated with a decreased risk of thyroid cancer (Table 1).
Table 1.

General characteristics of the study participants with the control group 1 in univariate analysis and multivariate conditional logistic regression analysis

VariableControl[a)] (n=802)Case (n=802)Crude OR (95% CI)Adjusted OR (95% CI)[b)]
Sex
 Male432 (53.9)229 (28.6)1.001.00
 Female370 (46.1)573 (71.5)2.97 (2.38-3.71)2.08 (1.26-3.45)
BMI (kg/m2)
 < 23307 (38.3)309 (38.5)1.001.00
 23-25218 (27.2)221 (27.6)1.01 (0.79-1.29)1.21 (0.85-1.72)
 > 25277 (34.5)272 (33.9)0.98 (0.77-1.23)1.23 (0.88-1.72)
Family history of cancer[c)]
 No211 (26.3)246 (30.7)1.001.00
 Yes585 (72.9)543 (67.7)0.79 (0.63-0.99)0.74 (0.54-1.02)
 Missing6 (0.8)13 (1.6)
Family history of thyroid cancer[c)]
 No785 (97.9)748 (93.3)1.001.00
 Yes11 (1.4)41 (5.1)3.64 (1.87-7.09)4.39 (1.73-11.15)
 Missing6 (0.8)13 (1.6)
Education
 Middle school or below121 (15.1)139 (17.3)1.001.00
 High school263 (32.8)260 (32.4)0.82 (0.60-1.12)1.06 (0.66-1.69)
 College or above409 (51.0)350 (43.6)0.67 (0.49-0.92)1.19 (0.72-1.97)
 Missing9 (1.1)53 (6.6)
Occupation
 Housewife228 (28.4)349 (43.5)1.001.00
 Profession/Office worker329 (41.0)229 (28.6)0.46 (0.36-0.59)1.11 (0.26-1.76)
 Sales/Service122 (15.2)100 (12.5)0.55 (0.40-0.76)1.07 (0.66-1.71)
 Agriculture/Laborer/Unemployed/Others114 (14.2)80 (10.0)0.47 (0.32-0.66)0.99 (0.56-1.76)
 Missing9 (1.1)44 (5.5)
Monthly household income
 < $1,853[d)]82 (10.2)107 (13.3)1.001.00
 $1,853-$3,706221 (27.6)224 (27.9)0.65 (0.44-0.97)0.72 (0.44-1.19)
 > $3,706429 (53.5)329 (41.0)0.49 (0.33-0.71)0.59 (0.36-0.98)
 Missing70 (8.7)142 (17.7)
Marital status
 Married741 (92.4)674 (84.0)1.001.00
 Unmarried26 (3.2)25 (3.1)1.01 (0.55-1.87)0.70 (0.31-1.62)
 Divorced/Widowed35 (4.4)74 (9.2)2.38 (1.54-3.67)1.67 (0.87-3.22)
 Missing029 (3.6)
Alcohol consumption
 Non-drinker236 (29.4)360 (44.9)1.001.00
 Former drinker30 (3.7)45 (5.6)1.05 (0.63-1.76)1.79 (0.87-3.71)
 Current drinker520 (64.8)373 (46.5)0.46 (0.36-0.57)0.92 (0.66-1.30)
 Ever-drinker550 (49.0)418 (25.7)0.50 (0.40-0.61)0.81 (0.63-1.06)
 Missing16 (2.0)24 (3.0)
Smoking status
 Non-smoker382 (47.6)547 (68.2)1.001.00
 Former smoker178 (22.2)109 (13.6)0.43 (0.33-0.58)0.75 (0.48-1.17)
 Current smoker215 (26.8)97 (12.1)0.29 (0.22-0.40)0.49 (0.31-0.78)
 Ever-smoker393 (49.0)206 (25.7)0.34 (0.27-0.43)0.62 (0.44-0.86)
 Missing27 (3.4)49 (6.1)

OR, odds ratio; CI, confidence interval; BMI, body mass index.

Matched to cases by age (within 2 years) and residential areas,

Adjusted for BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status; R2=0.1277,

First degree relatives,

$1=1,079 Korean won (as of April 26, 2015).

Table 1 also lists the findings from multivariate conditional logistic regression analysis adjusted for sex, BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status. The results showed that females (OR, 2.08; 95% CI, 1.26 to 3.45) and a family history of thyroid cancer (OR, 4.39; 95% CI, 1.73 to 11.15) were more likely to have an increased risk of thyroid cancer, whereas higher household incomes (> $3,706 vs. < $1,853; OR, 0.59; 95% CI, 0.36 to 0.98) and ever-smokers (OR, 0.62; 95% CI, 0.44 to 0.86) were more likely to have a decreased risk of thyroid cancer. On the other hand, there was no significant association observed with BMI, family history of cancer, education levels, occupational, marital status, and alcohol consumption. In multivariate conditional logistic regression analysis according to the smoking history, compared to non-smokers, there was a dose-response relationship in the ever-smokers between the years of cigarette smoking and a decreased risk of thyroid cancer (OR, 0.87; 95% CI, 0.50 to 1.50 for ≤ 10 years; OR, 0.61; 95% CI, 0.39 to 0.95 for 11-20 years; OR, 0.59; 95% CI, 0.37 to 0.95 for 21-30 years; OR, 0.62; 95% CI, 0.35 to 1.10 for > 30 years; p-value for trend=0.019) (Table 2). On the other hand, no dose-response relationship was observed for the age when they started to smoke and the number of daily cigarette smoking.
Table 2.

Association between the risk of thyroid cancer and smoking history, such as age at starting to smoke, years of cigarette smoking, and number of daily cigarette smoking in multivariate conditional logistic regression analysis

VariableControl (n=802)Case (n=802)Crude OR (95% CI)Adjusted OR (95% CI)[a)]
Age at starting to smoke
 Never smoking382 (47.6)547 (68.2)1.001.00
 ≤ 1874 (9.2)31 (3.9)0.26 (0.17-0.42)0.52 (0.29-0.93)
 19-24223 (27.8)121 (15.1)0.36 (0.28-0.48)0.76 (0.52-1.12)
 ≥ 2554 (6.7)28 (3.5)0.38 (0.23-0.62)0.57 (0.33-1.01)
 Missing69 (8.6)75 (9.4)
 p-value for trend< 0.0010.133
Years of cigarette smoking
 Never smoking382 (47.6)547 (68.2)1.001.00
 ≤ 1040 (5.0)34 (4.2)0.60 (0.37-0.99)0.87 (0.50-1.50)
 11-20122 (15.2)58 (7.2)0.33 (0.23-0.47)0.61 (0.39-0.95)
 21-30128 (16.0)62 (7.7)0.30 (0.20-0.43)0.59 (0.37-0.95)
 > 3071 (8.9)29 (3.6)0.29 (0.18-0.47)0.62 (0.35-1.10)
 Missing59 (7.4)72 (9.0)
 p-value for trend< 0.0010.019
No. of cigarettes/day
 Never smoking382 (47.6)547 (68.2)1.001.00
 ≤ 10110 (13.7)58 (7.2)0.35 (0.25-0.50)0.61 (0.40-0.93)
 11-20180 (22.4)101 (12.6)0.39 (0.29-0.52)0.84 (0.56-1.26)
 21-3048 (6.0)16 (2.0)0.23 (0.12-0.41)0.42 (0.22-0.82)
 > 3025 (3.1)11 (1.4)0.27 (0.13-0.56)0.61 (0.26-1.42)
 Missing57 (7.1)69 (8.6)
 p-value for trend< 0.0010.071

OR, odds ratio; CI, confidence interval.

Adjusted for sex, body mass index, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, smoking status, and alcohol consumption; R2=0.1070.

Table 3 lists the general characteristics of the study participants with the same case group and the control group 2 in univariate analysis and multivariate conditional logistic regression analysis. In multivariate conditional logistic regression analysis, a family history of cancer and alcohol consumption were associated with a decreased risk of thyroid cancer, whereas a higher BMI and a family history of thyroid cancer were associated with an increased risk of thyroid cancer. Unlike the findings from multivariate analysis using control group 1, smoking was not associated with a risk of thyroid cancer.
Table 3.

General characteristics of the study participants with the control group 2 in univariate analysis and multivariate conditional logistic regression analysis

VariableControl[a)] (n=802)Case (n=802)Crude OR (95% CI)Adjusted OR (95% CI)[b)]
Sex
 Male229 (28.6)229 (28.6)--
 Female573 (71.5)573 (71.5)--
BMI (kg/m2)
 < 23353 (44.0)309 (38.5)1.001.00
 23-25225 (28.1)221 (27.6)1.14 (0.89-1.46)1.28 (0.98-1.68)
 > 25224 (27.9)272 (33.9)1.11 (1.11-1.80)1.42 (1.09-1.85)
Family history of cancer[c)]
 No187 (23.3)246 (30.7)1.001.00
 Yes606 (75.6)543 (67.7)0.66 (0.52-0.83)0.63 (0.49-0.81)
 Missing9 (1.1)13 (1.6)
Family history of thyroid cancer[c)]
 No787 (98.1)748 (93.3)1.001.00
 Yes6 (0.8)41 (5.1)8.00 (3.16-20.27)9.41 (3.61-24.51)
 Missing9 (1.1)13 (1.6)
Education
 Middle school or below159 (19.8)139 (17.3)1.001.00
 High school276 (34.4)260 (32.4)1.08 (0.80-1.45)1.19 (0.86-1.66)
 College or above353 (44.0)350 (43.6)1.15 (0.85-1.57)1.29 (0.90-1.86)
 Missing14 (1.8)53 (6.6)
Occupation
 Housewife344 (42.9)349 (43.5)1.001.00
 Profession/Office worker229 (28.6)229 (28.6)0.94 (0.70-1.24)0.87 (0.63-1.20)
 Sales/Service113 (14.1)100 (12.5)0.84 (0.61-1.17)0.77 (0.53-1.10)
 Agriculture/Laborer/Unemployed/Others101 (12.6)80 (10.0)0.75 (0.53-1.07)0.69 (0.47-1.02)
 Missing15 (1.9)44 (5.5)
Monthly household income
 < $1,853[d)]103 (12.8)107 (13.3)1.001.00
 $1,853-$3,706215 (26.8)224 (27.9)0.99 (0.71-1.38)0.95 (0.66-1.39)
 > $3,706389 (48.5)329 (41.0)0.79 (0.57-1.08)0.71 (0.49-1.03)
 Missing95 (11.9)142 (17.7)
Marital status
 Married710 (88.5)674 (84.0)1.001.00
 Unmarried20 (2.5)25 (3.1)1.33 (0.72-2.44)1.31 (0.68-2.50)
 Divorced/Widowed70 (8.7)74 (9.2)1.21 (0.84-1.75)1.25 (0.84-1.86)
 Missing2 (0.3)29 (3.6)
Alcohol consumption
 Non-drinker298 (37.2)360 (44.9)1.001.00
 Former drinker34 (4.2)45 (5.6)1.06 (0.66-1.71)1.13 (0.68-1.88)
 Current drinker455 (56.7)373 (46.5)0.61 (0.48-0.78)0.64 (0.49-0.82)
 Ever-drinker489 (61.0)418 (25.7)1.21 (0.62-2.35)0.68 (0.53-0.87)
 Missing15 (1.9)24 (3.0)
Smoking status
 Non-smoker541 (67.5)547 (68.2)1.001.00
 Former smoker104 (13.0)109 (13.6)0.97 (0.66-1.45)0.97 (0.63-1.48)
 Current smoker114 (14.2)97 (12.1)0.79 (0.55-1.13)0.82 (0.55-1.22)
 Ever-smoker218 (27.2)206 (25.7)0.86 (0.63-1.19)0.88 (0.62-1.25)
 Missing43 (5.4)49 (6.1)

OR, odds ratio; CI, confidence interval; BMI, body mass index.

Matched to cases by age (within 2 years), residential areas, and sex,

Adjusted for BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status; R2=0.0711,

First degree relatives,

$1=1,079 Korean won (as of April 26, 2015).

Discussion

This hospital-based case-control study found that females and those with a family history of thyroid cancer had an increased risk of thyroid cancer. In contrast, ever-smokers and those with higher household incomes were more likely to have a lower risk of thyroid cancer. In particular, an inverse dose-response association was observed between the years of cigarette smoking and the thyroid cancer risk. When the analysis was performed using the control group matched by sex as well as age and residential areas, alcohol consumption was significantly associated with a decreased risk of thyroid cancer. Overall, these findings are consistent with those of previous studies and reports on the general characteristics and risk factors of thyroid cancer. According to the GLOBOCAN 2012 of the International Agency of Research on Cancer, the age-standardized incidence rate of thyroid cancer worldwide was approximately 3.2 times higher in women than in men: 6.1 per 100,000 and 1.9 per 100,000, respectively [11]. In addition, the incidence data obtained from the Korea National Cancer Incidence Database showed that age-standardized incidence rates per 100,000 were 102.4 in women and 23.0 in men [12], which were approximately 4.5 times higher in women than in men. These results show that thyroid cancer is 3-4 times more common in women than in men. This study also showed that the risk of thyroid cancer was more than 2 times higher in women than in men. The reasons for the difference in incidence between men and women is unclear. However, estrogen, which is one of the two main female sex hormones, might explain the sex difference in the incidence of thyroid cancer. Several studies have shown that the estrogen levels might be associated with the risk of thyroid cancer. For example, although the frequency of differentiated thyroid cancer (papillary or parafollicular thyroid cancer) in girls was similar to that in boys up to the age of 12 years, with the onset of puberty, it increased in girls [13]. In addition, pregnancy was associated with an increased risk of thyroid cancer [14,15]. The onset of puberty and pregnancy are associated with increased levels of estrogen. In contrast, the incidence of thyroid cancer was highest in the late 40s and early 50s (perimenopause) and decreased thereafter (postmenopause) [12]. During these periods, the estrogen levels start to decrease rapidly and level off. As a potential mechanism for the impact of estrogen on the increased risk of thyroid cancer, several experimental studies have shown that 17β-estradiol (E2, predominant estrogen during reproductive periods) is a potent stimulating agent of both benign and malignant thyroid cells [16-18]. E2 acts via a classical genomic pathway mediated through the estrogen receptors α and β (ERα and ERβ) and a non-genomic pathway by membrane-associated estrogen receptor [19]. Both pathways are operative in benign and malignant thyroid tissues, even though the detection of ERs in normal thyroid tissues, thyroid adenomas, goiters, and thyroid carcinomas by immunohistochemical staining or reverse transcription polymerase chain reaction varies between 0% and 100% of samples [18,19]. Nevertheless, the influence of estrogen on the development of thyroid cancer is still unclear. Further detailed studies will be necessary to confirm the association between estrogen and thyroid cancer. A family history of thyroid cancer was also found to be associated with an increased risk of thyroid cancer. The increased risk of differentiated thyroid cancer was associated with a family history of thyroid cancer from the previous observational studies [20]. In addition, a recent population-based cohort study with 63,495 first-degree relatives of 11,206 non-medullary thyroid cancer patients reported a three-fold increase over the general population risk (standardized incidence ratio, 2.9; 95% CI, 2.4 to 3.4) [21]. Interestingly, in contrast to most of common cancers, this study showed that smoking was associated with a decreased risk of thyroid cancer (ever-smoker vs. non-smoker; OR, 0.62; 95% CI, 0.44 to 0.86). This finding is consistent with those from previous meta-analyses of case-control studies. In 2003, a pooled analysis of 14 case-control studies reported a reduced risk of thyroid cancer in current smokers [22]. In addition, a recent meta-analysis published in 2014 demonstrated an inverse association in subgroup meta-analysis of case-control studies (ever-smoker vs. non-smoker; OR, 0.79; 95% CI, 0.70 to 0.88) [8]. Similarly, in a pooled analysis of five prospective studies, smoking was associated with a lower risk of thyroid cancer in current smokers compared to never smokers (HR, 0.68; 95% CI, 0.55 to 0.85) [7]. Several potential biological mechanisms have been suggested to explain the reduced risk of thyroid cancer in smokers. First, smoking can lead to lower levels of thyroid stimulating hormone (TSH), which plays an important role in the development of thyroid cancer [23]. Second, smoking has an anti-estrogenic effect, which can result in a reduced risk of thyroid cancer [19]. Finally, smokers are less likely to be overweight or obese, which might be associated with an increased risk of thyroid cancer. In 2012, a meta-analysis of seven cohort studies found that overweight and obesity were linked to an 18% increased risk of thyroid cancer in men and women [6]. In the present findings, higher household incomes were more likely to have a decreased risk of thyroid cancer (> $3,706 vs. < $1,853; OR, 0.59; 95% CI, 0.36 to 0.98). On the other hand, previous studies have reported that higher socioeconomic status (SES) groups were more likely to show an increased risk of thyroid cancer compared to lower SES groups in the United States [24]. In particular, the incidence of thyroid cancer showed a less pronounced increase in low SES groups (6.7% per year) than that in the high SES groups (8.6% per year) in the United States. White Americans showed a steady increase in both the low and high SES groups, while African-Americans and Hispanics with a higher SES showed a more noticeable increase compared to the lower SES groups from 1995 to 2008 [24]. This issue may reflect the limitation in accessing health care services in low SES groups and minorities due to the low health insurance coverage [24]. This discrepancy cannot be explained at present; therefore, further studies will be required. Additionally, alcohol consumption was found to be significantly associated with a decreased risk of thyroid cancer when the analysis was performed using the control group matched by sex as well as age and residential areas. This finding is consistent with those from the previous pooled analysis of five cohort studies published in 2012 [7]. The possible biological mechanisms include decreased levels of TSH and the direct toxic effects of alcohol consumption [25,26]. This study has several limitations. First, the thyroid cancer cases were not confirmed based on the medical records and chart reviews. The thyroid cancer cases were ascertained by a linkage to the KCCR database based on the ICD-O (code C73), which may lead to ascertainment bias. Therefore, the specific type of thyroid cancer could not be defined in each case. On the other hand, it would be reasonable to assume that most of the cases included in the present study were papillary thyroid cancers because 94.2% of all incident thyroid cancers from 1997 to 2011 were papillary thyroid cancer according to the Korea National Cancer Incidence Database [27]. Second, the controls were also not confirmed from their medical records and chart reviews. On the other hand, the possibility of ascertainment bias might be minimal, if any, because the KCCR database covers almost all incident cancer cases, including thyroid cancer nationwide in Korea. Therefore, there would be little likelihood of the thyroid cancer cases being included in the control group of this study. Third, due to a lack of data, this study was unable to investigate the influence of previous exposure to radiation on thyroid cancer, which is a proven risk factor for thyroid cancer. Finally, recall bias might still exist as some data were collected retrospectively. In addition, these findings might not be applicable to the general population because the participants included in this study were recruited from one specific hospital screening center. To the best of the authors’ knowledge, this is the second largest case-control study on the risk factors of thyroid cancer since Kreiger and Parkes’s study in 2000 [28]. Therefore, this study provides more precision on this issue than most previous individual studies.

Conclusion

This hospital-based case-control study found that females, higher BMI, and those with a family history of thyroid cancer were significantly associated with an increased risk of thyroid cancer, whereas ever-smokers, drinkers, and those with higher household incomes were associated with a decreased risk of thyroid cancer. Nevertheless, these findings should be explored in further larger epidemiological studies with a higher level of evidence, such as prospective cohort studies.
  23 in total

1.  Reproductive factors and risk of papillary thyroid cancer in women.

Authors:  M A Rossing; L F Voigt; K G Wicklund; J R Daling
Journal:  Am J Epidemiol       Date:  2000-04-15       Impact factor: 4.897

Review 2.  Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure?

Authors:  Leonard Wartofsky
Journal:  Hormones (Athens)       Date:  2010 Apr-Jun       Impact factor: 2.885

3.  Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology.

Authors:  J Farahati; P Bucsky; T Parlowsky; U Mäder; C Reiners
Journal:  Cancer       Date:  1997-12-01       Impact factor: 6.860

4.  Thyroid cancer risk and smoking status: a meta-analysis.

Authors:  Young Ae Cho; Jeongseon Kim
Journal:  Cancer Causes Control       Date:  2014-07-01       Impact factor: 2.506

5.  Korea's thyroid-cancer "epidemic"--screening and overdiagnosis.

Authors:  Hyeong Sik Ahn; Hyun Jung Kim; H Gilbert Welch
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

6.  Serum TSH levels in smokers and non-smokers. The 5th Tromsø study.

Authors:  R Jorde; J Sundsfjord
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-07       Impact factor: 2.949

7.  Family history of cancer and risk of sporadic differentiated thyroid carcinoma.

Authors:  Li Xu; Guojun Li; Qingyi Wei; Adel K El-Naggar; Erich M Sturgis
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

Review 8.  Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis.

Authors:  Daniela Schmid; Gundula Behrens; Carmen Jochem; Marlen Keimling; Michael Leitzmann
Journal:  Eur J Epidemiol       Date:  2013-11-17       Impact factor: 8.082

9.  Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway.

Authors:  Q Zeng; G G Chen; A C Vlantis; C A van Hasselt
Journal:  Cell Prolif       Date:  2007-12       Impact factor: 6.831

10.  Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Chang-Mo Oh; Hyunsoon Cho; Duk Hyoung Lee; Kang Hyun Lee
Journal:  Cancer Res Treat       Date:  2015-03-03       Impact factor: 4.679

View more
  21 in total

Review 1.  Total thyroidectomy versus thyroid lobectomy in the treatment of papillary carcinoma.

Authors:  Marco Raffaelli; Serena Elisa Tempera; Luca Sessa; Celestino Pio Lombardi; Carmela De Crea; Rocco Bellantone
Journal:  Gland Surg       Date:  2020-01

2.  The Effect of Gout on Thyroid Cancer Incidence: A Nested Case-Control Study Using a National Health Screening Cohort.

Authors:  So Young Kim; Dae Myoung Yoo; Mi Jung Kwon; Ji Hee Kim; Joo-Hee Kim; Woo Jin Bang; Sung Kyun Kim; Hyo Geun Choi
Journal:  J Pers Med       Date:  2022-05-27

3.  Seaweed and Iodine Intakes and SLC5A5 rs77277498 in Relation to Thyroid Cancer.

Authors:  Tung Hoang; Eun Kyung Lee; Jeonghee Lee; Yul Hwangbo; Jeongseon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2022-05-24

4.  Effect of Cigarette Smoking on Thyroid Cancer: Meta-Analysis.

Authors:  Joon-Hyop Lee; Young Jun Chai; Ka Hee Yi
Journal:  Endocrinol Metab (Seoul)       Date:  2021-05-26

5.  The Relationship Between Human Development Index and Its Components with Thyroid Cancer Incidence and Mortality: Using the Decomposition Approach.

Authors:  Mokhtar Soheylizad; Salman Khazaei; Ensiyeh Jenabi; Ali Delpisheh; Yousef Veisani
Journal:  Int J Endocrinol Metab       Date:  2018-10-20

Review 6.  Risk Factors for Thyroid Cancer: What Do We Know So Far?

Authors:  Tatjana Bogović Crnčić; Maja Ilić Tomaš; Neva Girotto; Svjetlana Grbac Ivanković
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

7.  Association among Body Mass Index, Genetic Variants of FTO, and Thyroid Cancer Risk: A Hospital-Based Case-Control Study of the Cancer Screenee Cohort in Korea.

Authors:  Tung Hoang; Dayoung Song; Jeonghee Lee; Eun Kyung Lee; Yul Hwangbo; Jeongseon Kim
Journal:  Cancer Res Treat       Date:  2020-12-07       Impact factor: 4.679

8.  Interplay between Body Size Measures and Thyroid Cancer Aggressiveness: A Retrospective Analysis.

Authors:  Thaís Gomes de Melo; Ligia Vera Montali da Assumpção; Denise Engelbrecht Zantut-Wittmann
Journal:  Int J Endocrinol       Date:  2018-08-27       Impact factor: 3.257

9.  Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females.

Authors:  Jeong-Hwa Choi; Jeonghee Lee; Sarah Yang; Eun Kyung Lee; Yul Hwangbo; Jeongseon Kim
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

10.  Thyroid cancer among female workers in Korea, 2007-2015.

Authors:  Seonghoon Kang; Jinho Song; Taehwan Koh; One Park; Jong-Tae Park; Won-Jin Lee
Journal:  Ann Occup Environ Med       Date:  2018-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.